Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders
-
Published:2024-06-25
Issue:1
Volume:16
Page:
-
ISSN:1866-1955
-
Container-title:Journal of Neurodevelopmental Disorders
-
language:en
-
Short-container-title:J Neurodevelop Disord
Author:
Roalf David R.ORCID, McDonald-McGinn Donna M., Jee Joelle, Krall Mckenna, Crowley T. Blaine, Moberg Paul J., Kohler Christian, Calkins Monica E., Crow Andrew J.D., Fleischer Nicole, Gallagher R. Sean, Gonzenbach Virgilio, Clark Kelly, Gur Ruben C., McClellan Emily, McGinn Daniel E., Mordy Arianna, Ruparel Kosha, Turetsky Bruce I., Shinohara Russell T., White Lauren, Zackai Elaine, Gur Raquel E.
Abstract
Abstract
Background
Minor physical anomalies (MPAs) are congenital morphological abnormalities linked to disruptions of fetal development. MPAs are common in 22q11.2 deletion syndrome (22q11DS) and psychosis spectrum disorders (PS) and likely represent a disruption of early embryologic development that may help identify overlapping mechanisms linked to psychosis in these disorders.
Methods
Here, 2D digital photographs were collected from 22q11DS (n = 150), PS (n = 55), and typically developing (TD; n = 93) individuals. Photographs were analyzed using two computer-vision techniques: (1) DeepGestalt algorithm (Face2Gene (F2G)) technology to identify the presence of genetically mediated facial disorders, and (2) Emotrics—a semi-automated machine learning technique that localizes and measures facial features.
Results
F2G reliably identified patients with 22q11DS; faces of PS patients were matched to several genetic conditions including FragileX and 22q11DS. PCA-derived factor loadings of all F2G scores indicated unique and overlapping facial patterns that were related to both 22q11DS and PS. Regional facial measurements of the eyes and nose were smaller in 22q11DS as compared to TD, while PS showed intermediate measurements.
Conclusions
The extent to which craniofacial dysmorphology 22q11DS and PS overlapping and evident before the impairment or distress of sub-psychotic symptoms may allow us to identify at-risk youths more reliably and at an earlier stage of development.
Funder
National Institute of Mental Health
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA, Zackai EH, Emanuel BS, Vermeesch JR, Morrow BE. 22q11. 2 deletion syndrome. Nat Reviews Disease Primers. 2015;1:15071. 2. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis. 1994;182(8):476–7. 3. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56(10):940–5. 4. Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL. Risk factors for the emergence of psychotic disorders in adolescents with 22q11. 2 deletion syndrome. Am J Psychiatry. 2007;164(4):663–9. 5. Schneider M, Van der Linden M, Menghetti S, Glaser B, Debbané M, Eliez S. Predominant negative symptoms in 22q11. 2 deletion syndrome and their associations with cognitive functioning and functional outcome. J Psychiatr Res. 2014;48(1):86–93.
|
|